112 related articles for article (PubMed ID: 25689528)
21. Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections.
Sanz-Rodriguez C; Lopez-Duarte M; Jurado M; Lopez J; Arranz R; Cisneros JM; Martino ML; Garcia-Sanchez PJ; Morales P; Olivé T; Rovira M; Solano C
Bone Marrow Transplant; 2004 Jul; 34(1):13-20. PubMed ID: 15122312
[TBL] [Abstract][Full Text] [Related]
22. [Treatment recommendations for invasive fungal disease in pediatric patients with cancer or blood disease].
Tang S; ; ; ;
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):426-9. PubMed ID: 25190161
[No Abstract] [Full Text] [Related]
23. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
24. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
Agarwal MB; Rathi SA; Ratho N; Subramanian R
J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
[TBL] [Abstract][Full Text] [Related]
25. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
Vagace JM; Sanz-Rodriguez C; Casado MS; Alonso N; Garcia-Dominguez M; de la Llana FG; Zarallo L; Fajardo M; Bajo R
BMC Infect Dis; 2007 May; 7():40. PubMed ID: 17493279
[TBL] [Abstract][Full Text] [Related]
26. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA
Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
28. Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey.
Turner SJ; Senol E; Kara A; Al-Badriyeh D; Dinleyici EC; Kong DC
Mycoses; 2014 Aug; 57(8):489-96. PubMed ID: 24635908
[TBL] [Abstract][Full Text] [Related]
29. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
30. Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.
Réminiac F; Sonneville R; Massias L; Chochillon C; Wolff M
Antimicrob Agents Chemother; 2014 Jun; 58(6):3568-9. PubMed ID: 24733459
[No Abstract] [Full Text] [Related]
31. A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study).
Cattaneo C; Monte S; Algarotti A; Audisio E; Borlenghi E; Campiotti L; Cerqui E; Fanizza C; Giuliani R; Micò C; Rocconi R; Salvi A; Salvi F; Verga L; Levis A; Lambertenghi Deliliers G; Pogliani EM; Tognoni G; Rambaldi A; Rossi G
J Antimicrob Chemother; 2011 Sep; 66(9):2140-5. PubMed ID: 21729932
[TBL] [Abstract][Full Text] [Related]
32. Comedication of caspofungin acetate and cyclosporine A after allogeneic haematopoietic stem cell transplantation leads to negligible hepatotoxicity.
Christopeit M; Eikam M; Behre G
Mycoses; 2008; 51 Suppl 1():19-24. PubMed ID: 18471157
[TBL] [Abstract][Full Text] [Related]
33. Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
Glasmacher A; Cornely OA; Orlopp K; Reuter S; Blaschke S; Eichel M; Silling G; Simons B; Egerer G; Siemann M; Florek M; Schnitzler R; Ebeling P; Ritter J; Reinel H; Schütt P; Fischer H; Hahn C; Just-Nuebling G
J Antimicrob Chemother; 2006 Jan; 57(1):127-34. PubMed ID: 16308418
[TBL] [Abstract][Full Text] [Related]
34. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.
Nivoix Y; Zamfir A; Lutun P; Kara F; Remy V; Lioure B; Rigolot JC; Entz-Werlé N; Letscher-Bru V; Waller J; Levêque D; Koffel JC; Beretz L; Herbrecht R
J Infect; 2006 Jan; 52(1):67-74. PubMed ID: 16368463
[TBL] [Abstract][Full Text] [Related]
35. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).
Jarque I; Tormo M; Bello JL; Rovira M; Batlle M; Julià A; Tabares S; Rivas C; Fernández-Sevilla A; García-Boyero R; Debén G; González-Campos J; Capote FJ; Sanz MA;
Med Mycol; 2013 Feb; 51(2):150-4. PubMed ID: 22712457
[TBL] [Abstract][Full Text] [Related]
36. Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies.
Mattiuzzi GN; Alvarado G; Giles FJ; Ostrosky-Zeichner L; Cortes J; O'brien S; Verstovsek S; Faderl S; Zhou X; Raad II; Bekele BN; Leitz GJ; Lopez-Roman I; Estey EH
Antimicrob Agents Chemother; 2006 Jan; 50(1):143-7. PubMed ID: 16377679
[TBL] [Abstract][Full Text] [Related]
37. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.
Candoni A; Mestroni R; Damiani D; Tiribelli M; Michelutti A; Silvestri F; Castelli M; Viale P; Fanin R
Eur J Haematol; 2005 Sep; 75(3):227-33. PubMed ID: 16104879
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
Maertens JA; Madero L; Reilly AF; Lehrnbecher T; Groll AH; Jafri HS; Green M; Nania JJ; Bourque MR; Wise BA; Strohmaier KM; Taylor AF; Kartsonis NA; Chow JW; Arndt CA; DePauw BE; Walsh TJ;
Pediatr Infect Dis J; 2010 May; 29(5):415-20. PubMed ID: 20431381
[TBL] [Abstract][Full Text] [Related]
39. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China.
Zhang X; Hu J; Hu Y; Huang H; Jin J; Li J; Liu Q; Shao Z; Wang J; Wang Q; Wu D; Huang X
Med Sci Monit; 2018 Jul; 24():5258-5270. PubMed ID: 30056458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
